Media, investors, advocacy organizations and others, please contact us here.

Publications

Access Travere’s peer-reviewed publications.

Year
Therapeutic Area
Product

Results 24

Sort by

Publications IgAN

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

View
Publications FSGS

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

View
Publications IgAN

IgA Nephropathy Patient Baseline Characteristicsin the Sparsentan PROTECT Study

View
Publications IgAN

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

View
Publications IgAN

Clinicopathological Characteristics of Adult IgA Nephropathy in the United States

View
Publications IgAN

Impact of Proteinuria and Kidney Function Decline on Health Care Costs and Resource Utilization in Adults With IgA Nephropathy in the United States: A Retrospective Analysis

View
Publications Nephrology

Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: An Open-Label Drug–Drug Interaction Study in Healthy Adults

View
Publications Nephrology

Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis

View
Publications IgAN

Long-Term Outcomes in IgA Nephropathy

View
Publications CTX

Allelic prevalence and geographicdistribution of cerebrotendinous xanthomatosis

View
Publications FSGS

Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis: Sparsentan DUET Trial

View
Publications HCU

Accurate 24‐h urine cystine quantification for patients on cystine‐binding thiol drugs

View

Contact Us

For more information, please click on the link below to be directed to our contact us form.

Adverse Event Reporting

To report suspected adverse reactions, contact Travere Therapeutics at 1-877-659-5518 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.